WHO ICTRP trial
bioequivalence study of Baclofen 25mg tablet of Amin Pharm Co., IRAN in…
IRCT20190706044111N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20190706044111N2 |
|---|---|
| Public title | bioequivalence study of Baclofen 25mg tablet of Amin Pharm Co., IRAN in comparison of Lioresal 25mg tablet of Novartis |
| Scientific title | A randomized, open label, two treatments, two periods, two sequence, single dose, crossover, bioequivalence study of Baclofen 25mg tablet of Amin Pharm Co., IRAN in comparison of Lioresal 25mg tablet of Novartis in 24 healthy man adult subjects under fasting condition |
| Primary sponsor | Amin Pharm. Co. |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | Bioequivalence |
| Countries | Iran (Islamic Republic of) |
| Conditions | Muscle spastic. |
| Interventions | Intervention 1: Intervention group: Baclofen 2* 25mg tablet of Amin Pharm Co.,. Intervention 2: Control group: Lioresal 25mg tablet of Novartis. |
| Registration date | Aug 14, 2019 |
| Target size | 24 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: